NEWS
See the latest PIR International News, Articles and Network Updates.
PIR International appoints SVP, Corporate and Commercial Strategy at NMD Pharma
PIR International is pleased to announce the placement of Daniel Brennan as SVP, Corporate and Commercial Strategy at NMD Pharma. NMD Pharma A/S is a clinical-stage biotech company leading in the development of novel first-in-class therapies for severe neuromuscular disorders. [...]
Michael Engsig – BioLeader Interview
Chief Executive Officer, Nykode Therapeutics (May 2023) Michael Engsig joined Nykode Therapeutics in 2017. He is a broadly anchored pharmaceutical professional with extensive experience, from early-stage drug discovery to late-stage development and product launches in biotech and pharma and [...]
Damian Marron – BioLeader Interview
Board Director Cantargia AB, Targovax ASA, CytoSeek, Imophoron, Resolys Bio (May 2023) Damian Marron is an experienced Board Chair and Non-Executive Director, corporate advisor and former serial Biotech CEO with a successful track record of value creation through public [...]
Özgür Tuncer – BioLeader Interview
Chief Executive Officer, Stablepharma, Board Director and Investor (April 2023) Özgür Tuncer has over two decades of experience in the biopharmaceutical industry with deep expertise in executive leadership, strategy, M&A and investments. Most recently, he was Global Vice President [...]